PLAB 1 → Musculoskeletal
Musculoskeletal accounts for roughly 4% of the PLAB 1 blueprint. This bank has 82 items tagged to it.
Around 4% of the paper, per GMC Medical Licensing Assessment content map. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 54 year old man has severe pain and swelling of the right first metatarsophalangeal joint that developed over six hours overnight. The joint is red, hot and exquisitely tender, and he cannot bear the weight of a bedsheet on it. He is afebrile and systemically well. He takes bendroflumethiazide and drinks eight pints of beer at weekends. His serum urate today is 340 µmol/L. What is the SINGLE most likely diagnosis?
The point: Gout is a severe, fast-developing infection-free arthritis in one joint (monoarthritis), most often the big toe joint (the first metatarsophalangeal joint). A blood urate level taken during an attack can come back normal, so a normal urate does NOT rule gout out. Measure urate at least two weeks after the attack has fully settled. Fluid taken from the joint (joint aspiration) shows needle-shaped crystals that block light in a specific way (negatively birefringent), and this test is essential whenever a joint infection is possible. Treat the attack with an anti-inflammatory painkiller (NSAID), colchicine, or a steroid, choosing based on the patient's other health problems: NSAIDs are avoided in kidney damage, heart failure and stomach ulcers, and colchicine's dose is limited by the diarrhoea it causes. Start allopurinol (a drug that lowers urate) after the attack, or during it with cover from another drug, and keep taking it through any further attacks rather than stopping. Aim for a urate level below 360 micromol per litre, or below 300 if the patient has urate lumps (tophi) or frequent attacks. Pseudogout, a different crystal disease, gives rhomboid-shaped crystals that block light the opposite way (positively birefringent), with a thin line of calcium seen on the joint X-ray (chondrocalcinosis).
Source: NICE NG219 — Gout: diagnosis and management NICE · tier 1, national regulator or guidance
A 54 year old man has severe pain and swelling of the right first metatarsophalangeal joint that developed over six hours overnight. The joint is red, hot and exquisitely tender, and he cannot bear the weight of a bedsheet on it. He is afebrile and systemically well. He takes bendroflumethiazide and drinks eight pints of beer at weekends. His serum urate today is 340 µmol/L. What is the SINGLE most appropriate initial investigation?
The point: Gout is a severe, fast-developing infection-free arthritis in one joint (monoarthritis), most often the big toe joint (the first metatarsophalangeal joint). A blood urate level taken during an attack can come back normal, so a normal urate does NOT rule gout out. Measure urate at least two weeks after the attack has fully settled. Fluid taken from the joint (joint aspiration) shows needle-shaped crystals that block light in a specific way (negatively birefringent), and this test is essential whenever a joint infection is possible. Treat the attack with an anti-inflammatory painkiller (NSAID), colchicine, or a steroid, choosing based on the patient's other health problems: NSAIDs are avoided in kidney damage, heart failure and stomach ulcers, and colchicine's dose is limited by the diarrhoea it causes. Start allopurinol (a drug that lowers urate) after the attack, or during it with cover from another drug, and keep taking it through any further attacks rather than stopping. Aim for a urate level below 360 micromol per litre, or below 300 if the patient has urate lumps (tophi) or frequent attacks. Pseudogout, a different crystal disease, gives rhomboid-shaped crystals that block light the opposite way (positively birefringent), with a thin line of calcium seen on the joint X-ray (chondrocalcinosis).
Source: NICE NG219 — Gout: diagnosis and management NICE · tier 1, national regulator or guidance
A 54 year old man has severe pain and swelling of the right first metatarsophalangeal joint that developed over six hours overnight. The joint is red, hot and exquisitely tender, and he cannot bear the weight of a bedsheet on it. He is afebrile and systemically well. He takes bendroflumethiazide and drinks eight pints of beer at weekends. His serum urate today is 340 µmol/L. What is the SINGLE most appropriate immediate management?
The point: Gout is a severe, fast-developing infection-free arthritis in one joint (monoarthritis), most often the big toe joint (the first metatarsophalangeal joint). A blood urate level taken during an attack can come back normal, so a normal urate does NOT rule gout out. Measure urate at least two weeks after the attack has fully settled. Fluid taken from the joint (joint aspiration) shows needle-shaped crystals that block light in a specific way (negatively birefringent), and this test is essential whenever a joint infection is possible. Treat the attack with an anti-inflammatory painkiller (NSAID), colchicine, or a steroid, choosing based on the patient's other health problems: NSAIDs are avoided in kidney damage, heart failure and stomach ulcers, and colchicine's dose is limited by the diarrhoea it causes. Start allopurinol (a drug that lowers urate) after the attack, or during it with cover from another drug, and keep taking it through any further attacks rather than stopping. Aim for a urate level below 360 micromol per litre, or below 300 if the patient has urate lumps (tophi) or frequent attacks. Pseudogout, a different crystal disease, gives rhomboid-shaped crystals that block light the opposite way (positively birefringent), with a thin line of calcium seen on the joint X-ray (chondrocalcinosis).
Source: NICE NG219 — Gout: diagnosis and management NICE · tier 1, national regulator or guidance
Acute and emergency · Cancer · Cardiovascular · Child health · Clinical haematology · Clinical imaging · Dermatology · Ear, nose and throat · Endocrine, diabetes and metabolic · Gastrointestinal · General practice and primary healthcare · Infection · Medicine of the older adult · Mental health · Neurosciences · Obstetrics and gynaecology · Ophthalmology · Palliative and end of life care · Perioperative medicine and anaesthesia · Renal and urology · Respiratory · Sexual health · Surgery